中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2011年
10期
674-678
,共5页
赵瑾%彭群新%杨炳华%卢大儒
趙瑾%彭群新%楊炳華%盧大儒
조근%팽군신%양병화%로대유
肺肿瘤%受体,表皮生长因子%突变%循环DNA%高分辨率熔解曲线分析
肺腫瘤%受體,錶皮生長因子%突變%循環DNA%高分辨率鎔解麯線分析
폐종류%수체,표피생장인자%돌변%순배DNA%고분변솔용해곡선분석
Lung neoplasms%Receptor,epidermal growth factor%Mutations%Circulating DNA%High-resolution melting analysis
目的 探讨高分辨熔解曲线(HRM)法检测肺癌患者血浆循环DNA中表皮生长因子受体(EGFR)基因突变的可行性.方法 采用HRM法对含不同比例EGFR基因突变型质粒的系列混合样本进行检测,以评价其灵敏度.应用HRM法检测2009年9月至2010年5月收治的96例肺癌患者血浆循环DNA中EGFR基因19、21外显子突变状况,并与基因测序法的结果比较分析.结果 HRM法可检出系列混合样本中突变型质粒比例为5%的突变,其检测灵敏度达5%.经HRM法,在96例肺癌患者中检测出17例发生了EGFR突变,突变率为17.7%,其中外显子19和21突变分别占88.2%(15/17)和11.8%(2/17);经基因测序法验证,结果完全一致.结论 HRM法检测EGFR简单易行,快速,敏感性较高,可作为临床EGFR突变筛查的优选方法.
目的 探討高分辨鎔解麯線(HRM)法檢測肺癌患者血漿循環DNA中錶皮生長因子受體(EGFR)基因突變的可行性.方法 採用HRM法對含不同比例EGFR基因突變型質粒的繫列混閤樣本進行檢測,以評價其靈敏度.應用HRM法檢測2009年9月至2010年5月收治的96例肺癌患者血漿循環DNA中EGFR基因19、21外顯子突變狀況,併與基因測序法的結果比較分析.結果 HRM法可檢齣繫列混閤樣本中突變型質粒比例為5%的突變,其檢測靈敏度達5%.經HRM法,在96例肺癌患者中檢測齣17例髮生瞭EGFR突變,突變率為17.7%,其中外顯子19和21突變分彆佔88.2%(15/17)和11.8%(2/17);經基因測序法驗證,結果完全一緻.結論 HRM法檢測EGFR簡單易行,快速,敏感性較高,可作為臨床EGFR突變篩查的優選方法.
목적 탐토고분변용해곡선(HRM)법검측폐암환자혈장순배DNA중표피생장인자수체(EGFR)기인돌변적가행성.방법 채용HRM법대함불동비례EGFR기인돌변형질립적계렬혼합양본진행검측,이평개기령민도.응용HRM법검측2009년9월지2010년5월수치적96례폐암환자혈장순배DNA중EGFR기인19、21외현자돌변상황,병여기인측서법적결과비교분석.결과 HRM법가검출계렬혼합양본중돌변형질립비례위5%적돌변,기검측령민도체5%.경HRM법,재96례폐암환자중검측출17례발생료EGFR돌변,돌변솔위17.7%,기중외현자19화21돌변분별점88.2%(15/17)화11.8%(2/17);경기인측서법험증,결과완전일치.결론 HRM법검측EGFR간단역행,쾌속,민감성교고,가작위림상EGFR돌변사사적우선방법.
Objective To discuss the practicability of detecting epidermal growth factor receptor (EGFR) mutations in plasma circulating DNA of lung cancer patients by high-resolution melting (HRM).Methods The sensitivity of HRM was analyzed by the detection of samples containing different proportions of EGFR-mutated plasmids.The mutations in exons 19 and 21 of EGFR were detected by HRM in 96 lung cancer patients from September 2009 to May 2010.And the results of HRM were compared with those of sequencing.Results The HRM detection could identify the EGFR mutations in a proportion of 5% of mutated plasmid DNA.And the EGFR mutations were detected in 17 (17.7%,17/96) cases.Among which,the number of exons 19 and 21 mutations was 15 (88.2%,15/17) and 2 (11.8%,2/17)respectively.The results of sequencing were consistent.Conclusion The HRM analysis may be an optimal method for clinical screening of EGFR mutation due to its simplicity and promptness with a high sensitivity.